Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -106.1% | +9005.6% | 2 / 3 | -7.3% | +3.42 pp | -5.69 pp | +7.6% | 0.59 | 29.38 | 1.864 | −7,3% | 9,5 | −92,3% | 29.38 | 47.52 | −38,2% |
| Pts | 0 | 12 | 8 | 0 | 12 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 50.600 (close price on 2026-10-19)EPS (TTM): 1.722
Financial charts
1.Revenue & growth
VND bn1.864Q2/26
1.Revenue & growth
VND bn1.864Q2/26
2.Profit & growth
VND bn-6,00Q2/26
3.Profit mix (Penman)
VND bn733Q2/26
4.Margins & cost structure
%19.7%Q2/26
5.Returns & cash cycle
% · days0.6%Q2/26
6.Earnings quality & cash
VND bn450Q2/26
7.Asset structure
VND bn12.755Q2/26
8.Funding & debt health
VND bn · times12.755Q2/26
9.Revenue backlog
VND bn33,4Q2/26
10.Valuation
times · %28,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-21Q2/26
Adjusted EPS growth, latest quarter
-106%
Average adjusted EPS growth, 3 quarters
135,5× higher
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26